Brokerages Set IperionX Limited Sponsored ADR (NASDAQ:IPX) Target Price at $55.33

IperionX Limited Sponsored ADR (NASDAQ:IPXGet Free Report) has earned an average recommendation of “Moderate Buy” from the five ratings firms that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation and four have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $55.3333.

Several research analysts have commented on IPX shares. Roth Mkm reissued a “buy” rating and issued a $74.00 price target on shares of IperionX in a report on Tuesday, January 20th. BTIG Research started coverage on IperionX in a research report on Friday, March 27th. They issued a “buy” rating and a $40.00 price objective on the stock. William Blair started coverage on IperionX in a research note on Tuesday, January 13th. They set an “outperform” rating for the company. Weiss Ratings restated a “sell (e+)” rating on shares of IperionX in a research report on Tuesday. Finally, B. Riley Financial decreased their target price on IperionX from $58.00 to $52.00 and set a “buy” rating on the stock in a research note on Friday, March 13th.

Read Our Latest Analysis on IPX

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Jones Financial Companies Lllp purchased a new position in IperionX in the 3rd quarter worth approximately $36,000. JPMorgan Chase & Co. bought a new stake in shares of IperionX during the 2nd quarter worth $66,000. State of Tennessee Department of Treasury purchased a new position in IperionX in the fourth quarter worth $119,000. Quadrature Capital Ltd increased its stake in IperionX by 42.8% in the fourth quarter. Quadrature Capital Ltd now owns 14,918 shares of the company’s stock valued at $540,000 after acquiring an additional 4,471 shares during the last quarter. Finally, DV Equities LLC bought a new position in IperionX in the fourth quarter valued at $178,000. 2.76% of the stock is currently owned by institutional investors.

IperionX Price Performance

NASDAQ:IPX opened at $29.72 on Tuesday. The company has a current ratio of 4.03, a quick ratio of 4.00 and a debt-to-equity ratio of 0.03. IperionX has a 52-week low of $19.43 and a 52-week high of $61.45. The business’s fifty day moving average is $35.34 and its 200 day moving average is $39.93.

IperionX (NASDAQ:IPXGet Free Report) last announced its quarterly earnings results on Saturday, January 31st. The company reported ($0.50) earnings per share for the quarter. As a group, equities research analysts forecast that IperionX will post -0.12 earnings per share for the current fiscal year.

IperionX Company Profile

(Get Free Report)

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.

Read More

Analyst Recommendations for IperionX (NASDAQ:IPX)

Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.